UK markets closed


LSE - LSE Delayed price. Currency in EUR
Add to watchlist
6.34+6.34 (-29.64%)
At close: 05:57PM BST


21, chemin de la sauvegarde
Longjumeau 69134
33 1 69 09 77 85

Full-time employees1,180

Key executives

NameTitlePayExercisedYear born
Mr. Jean-Louis MartinActing CEO & DirectorN/AN/AN/A
Mr. Eric MoissenotGen. Director of Fin. & Admin.N/AN/AN/A
Mr. Gérard GuillamotScientific DirectorN/AN/AN/A
Mr. Christophe Eychenne-BaronHead of R&DN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


PCAS SA develops and produces complex molecules for life sciences and technologies. The company was founded in 1962 and is headquartered in Longjumeau, France. PCAS SA is a subsidiary of Seqens SAS

Corporate governance

PCAS SA’s ISS governance QualityScore as of 1 March 2023 is 10. The pillar scores are Audit: 8; Board: 10; Shareholder rights: 9; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.